Oral Hypoglycemic Agents: Biguanides and Glitazones
Pulmonary Tuberculosis V
Pulmonary Tuberculosis I
Anthelminthic Agents
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Pulmonary Tuberculosis IV
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 20, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Amit Singhal1, Liu Jie2, Pavanish Kumar2
1Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore. amit_singhal@immunol.a-star.edu.sg gennaro_delibero@immunol.a-star.edu.sg.
The antidiabetic drug metformin reduces Mycobacterium tuberculosis growth by enhancing host immune responses. Metformin shows promise as an adjunctive therapy for tuberculosis, improving treatment efficacy and reducing disease severity.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: